Transaction in Own Shares

Summary by AI ^BETAClose X

Caledonia Investments plc announced on 4 November 2025 that it executed a share buyback on 3 November 2025, purchasing 100,000 of its own ordinary shares through Peel Hunt LLP. The shares were acquired at an average price of 382.00 pence per share and are slated for cancellation. This transaction will reduce the company's total issued share capital with voting rights to 523,173,743 Ordinary Shares, a strategic move often undertaken to enhance shareholder value by potentially increasing earnings per share and supporting the stock price.

Disclaimer*

Caledonia Investments PLC

04 November 2025

Caledonia Investments plc

Transaction in own shares

Caledonia Investments plc ("Caledonia") announces that on 3 November 2025 it purchased 100,000 of its own ordinary shares of 0.5 pence each ("Ordinary Shares") through Peel Hunt LLP at an average price of 382.00 pence per share. The purchased Ordinary Shares will be cancelled.

	Number of ordinary shares purchased:	100,000
	Lowest price per share paid (pence):	382.00
	Highest price per share paid (pence):	382.00
	Weighted average price paid (pence):	382.00

Following the above transaction, Caledonia's issued share capital includes 523,173,743 Ordinary Shares with voting rights.

For further information, please contact:

Alex Pollard

Senior Assistant Company Secretary

Caledonia Investments plc

Telephone +44 20 7802 8080

4 November 2025

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END